Milly E. de Jonge

1.2k total citations
17 papers, 867 citations indexed

About

Milly E. de Jonge is a scholar working on Pathology and Forensic Medicine, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Milly E. de Jonge has authored 17 papers receiving a total of 867 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 9 papers in Oncology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Milly E. de Jonge's work include Chemotherapy-induced organ toxicity mitigation (12 papers), Acute Lymphoblastic Leukemia research (7 papers) and Cancer Treatment and Pharmacology (7 papers). Milly E. de Jonge is often cited by papers focused on Chemotherapy-induced organ toxicity mitigation (12 papers), Acute Lymphoblastic Leukemia research (7 papers) and Cancer Treatment and Pharmacology (7 papers). Milly E. de Jonge collaborates with scholars based in Netherlands. Milly E. de Jonge's co-authors include Jos H. Beijnen, Alwin D. R. Huitema, Sjoerd Rodenhuis, Jan H.M. Schellens, Hilde Rosing, M. Holtkamp, Corine Ekhart, M. J. X. Hillebrand, Ron A. A. Mathôt and Nico van Zandwijk and has published in prestigious journals such as Clinical Cancer Research, British Journal of Cancer and Clinical Pharmacokinetics.

In The Last Decade

Milly E. de Jonge

17 papers receiving 844 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Milly E. de Jonge Netherlands 14 282 219 211 150 128 17 867
Song Ren China 13 256 0.9× 155 0.7× 223 1.1× 130 0.9× 229 1.8× 33 953
Torben Stamm Mikkelsen Denmark 13 388 1.4× 251 1.1× 200 0.9× 125 0.8× 186 1.5× 37 1.1k
Donna Skee United States 16 120 0.4× 257 1.2× 161 0.8× 76 0.5× 173 1.4× 26 959
David R. Taft United States 17 420 1.5× 139 0.6× 339 1.6× 64 0.4× 73 0.6× 58 925
Brian P. Monahan United States 12 295 1.0× 245 1.1× 187 0.9× 104 0.7× 78 0.6× 22 931
Christopher James United States 17 169 0.6× 255 1.2× 80 0.4× 54 0.4× 106 0.8× 49 993
Junmin Zhou United States 19 447 1.6× 539 2.5× 206 1.0× 116 0.8× 187 1.5× 55 1.5k
Preben Jakobsen Denmark 17 193 0.7× 220 1.0× 135 0.6× 46 0.3× 49 0.4× 36 815
Toshihiro Oguma Japan 22 203 0.7× 398 1.8× 53 0.3× 46 0.3× 117 0.9× 34 1.7k
Karen May Germany 14 478 1.7× 176 0.8× 147 0.7× 57 0.4× 32 0.3× 25 921

Countries citing papers authored by Milly E. de Jonge

Since Specialization
Citations

This map shows the geographic impact of Milly E. de Jonge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milly E. de Jonge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milly E. de Jonge more than expected).

Fields of papers citing papers by Milly E. de Jonge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Milly E. de Jonge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milly E. de Jonge. The network helps show where Milly E. de Jonge may publish in the future.

Co-authorship network of co-authors of Milly E. de Jonge

This figure shows the co-authorship network connecting the top 25 collaborators of Milly E. de Jonge. A scholar is included among the top collaborators of Milly E. de Jonge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Milly E. de Jonge. Milly E. de Jonge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Jonge, Milly E. de, Alwin D. R. Huitema, Jos H. Beijnen, & Sjoerd Rodenhuis. (2006). High exposures to bioactivated cyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapy. British Journal of Cancer. 94(9). 1226–1230. 55 indexed citations
2.
Ekhart, Corine, Milly E. de Jonge, Alwin D. R. Huitema, et al.. (2006). Flat Dosing of Carboplatin Is Justified in Adult Patients with Normal Renal Function. Clinical Cancer Research. 12(21). 6502–6508. 41 indexed citations
3.
Jonge, Milly E. de, Alwin D. R. Huitema, Sjoerd Rodenhuis, & Jos H. Beijnen. (2005). Clinical Pharmacokinetics of Cyclophosphamide. Clinical Pharmacokinetics. 44(11). 1135–1164. 333 indexed citations
4.
Jonge, Milly E. de, Alwin D. R. Huitema, Jan H.M. Schellens, Sjoerd Rodenhuis, & Jos H. Beijnen. (2005). Individualised Cancer Chemotherapy: Strategies and Performance of Prospective Studies on Therapeutic Drug Monitoring with Dose Adaptation. Clinical Pharmacokinetics. 44(2). 147–173. 88 indexed citations
5.
Jonge, Milly E. de, et al.. (2005). Aprepitant inhibits cyclophosphamide bioactivation and thiotepa metabolism. Cancer Chemotherapy and Pharmacology. 56(4). 370–378. 52 indexed citations
6.
Jonge, Milly E. de, et al.. (2005). Significant induction of cyclophosphamide and thiotepa metabolism by phenytoin. Cancer Chemotherapy and Pharmacology. 55(5). 507–510. 27 indexed citations
7.
8.
Jonge, Milly E. de, et al.. (2005). Effects of co-medicated drugs on cyclophosphamide bioactivation in human liver microsomes. Anti-Cancer Drugs. 16(3). 331–336. 11 indexed citations
9.
Zandvliet, Anthe S., Alwin D. R. Huitema, Milly E. de Jonge, et al.. (2005). Population Pharmacokinetics of Caffeine and its Metabolites Theobromine, Paraxanthine and Theophylline after Inhalation in Combination with Diacetylmorphine. Basic & Clinical Pharmacology & Toxicology. 96(1). 71–79. 19 indexed citations
10.
Jonge, Milly E. de, Alwin D. R. Huitema, Jan H.M. Schellens, Sjoerd Rodenhuis, & Jos H. Beijnen. (2005). Population pharmacokinetics of orally administered paclitaxel formulated in Cremophor EL. British Journal of Clinical Pharmacology. 59(3). 325–334. 22 indexed citations
11.
Jonge, Milly E. de, Alwin D. R. Huitema, Sjoerd Rodenhuis, & Jos H. Beijnen. (2005). Sparse Sampling Design for Therapeutic Drug Monitoring of Sequentially Administered Cyclophosphamide, Thiotepa, and Carboplatin (CTC). Therapeutic Drug Monitoring. 27(3). 393–402. 4 indexed citations
12.
13.
14.
Jonge, Milly E. de, Alwin D. R. Huitema, Sjoerd Rodenhuis, & Jos H. Beijnen. (2004). Integrated Population Pharmacokinetic Model of Both Cyclophosphamide and Thiotepa Suggesting a Mutual Drug–Drug Interaction. Journal of Pharmacokinetics and Pharmacodynamics. 31(2). 135–156. 23 indexed citations
15.
16.
Jonge, Milly E. de, H.J.G.D. van den Bongard, Alwin D. R. Huitema, et al.. (2004). Bayesian Pharmacokinetically Guided Dosing of Paclitaxel in Patients with Non-Small Cell Lung Cancer. Clinical Cancer Research. 10(7). 2237–2244. 44 indexed citations
17.
Jonge, Milly E. de, et al.. (2003). Sorption of Thiotepa to Polyurethane Catheter Causes Falsely Elevated Plasma Levels. Therapeutic Drug Monitoring. 25(3). 261–263. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Song Ren Breakdown of academic impact, for papers by Torben Stamm Mikkelsen Breakdown of academic impact, for papers by Donna Skee Breakdown of academic impact, for papers by David R. Taft Breakdown of academic impact, for papers by Brian P. Monahan Breakdown of academic impact, for papers by Christopher James Breakdown of academic impact, for papers by Junmin Zhou Breakdown of academic impact, for papers by Preben Jakobsen Breakdown of academic impact, for papers by Toshihiro Oguma Breakdown of academic impact, for papers by Karen May
Rankless by CCL
2026